Easywell Biomedicals (1799.TWO) Earnings Analysis
Easywell Biomedicals (1799.TWO) has no confirmed upcoming earnings date. Trailing P/E -77.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1799.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 1799.TWO. This page updates as the calendar is published.
1799.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | -0.17196 TWD | n/a | n/a | n/a |
| 2024-09-30 | -0.05 TWD | n/a | n/a | n/a |
1799.TWO valuation and analyst view
| Trailing P/E | -77.38 |
|---|---|
| Trailing EPS | -0.38458 TWD |
| Price / book | 6.20 |
| Dividend yield | 0.00% |
| Market cap | 4.12B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Easywell Biomedicals (1799.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 1799.TWO. This page updates as the calendar is published.
Did 1799.TWO beat earnings last quarter?
Consensus estimate data was not available for 1799.TWO's 2024-12-31 report.
What is 1799.TWO's current P/E ratio and EPS?
1799.TWO trades at a trailing P/E of -77.38 on trailing EPS of -0.3845839803454133 TWD.
What do analysts rate 1799.TWO?
1799.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.